(+)-fenchone

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: (+)-fenchone
• 英文别名: (1s)-1,3,3-Trimethyl-norbornan-2-one；(1S)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-one
• 化学式: C₁₀H₁₆O
• 分子量: 152.236
• InChiKey: LHXDLQBQYFFVNW-MHPPCMCBSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.9
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  METHYLTITANIUM TRIISOPROPOXIDE 、 (+)-fenchone 以 异辛烷 为溶剂， 反应 10.0h， 以84%的产率得到(S)-1,2,3,3-Tetramethyl-bicyclo[2.2.1]heptan-2-ol
  参考文献：
  名称：

  甲基三异丙氧基钛，一种高度选择性的亲核甲基化试剂。初步沟通†

  摘要：

  钛替代锂或镁可以提供具有高选择性的亲核有机金属试剂，如标题化合物1所示（请参见表1-3）。

  DOI：

  10.1002/hlca.19800630839

文献信息

• BITTER TASTE MODIFIERS INCLUDING SUBSTITUTED 1-BENZYL-3-(1-(ISOXAZOL-4-YLMETHYL)-1H-PYRAZOL-4-YL)IMIDAZOLIDINE-2,4-DIONES AND COMPOSITIONS THEREOF
  申请人：SENOMYX, INC.

  公开号：US20160376263A1

  公开（公告）日：2016-12-29

  The present invention includes compounds and compositions known to modify the perception of bitter taste, and combinations of said compositions and compounds with additional compositions, compounds, and products. Exemplary compositions comprise one or more of the following: cooling agents; inactive drug ingredients; active pharmaceutical ingredients; food additives or foodstuffs; flavorants, or flavor enhancers; food or beverage products; bitter compounds; sweeteners; bitterants; sour flavorants; salty flavorants; umami flavorants; plant or animal products; compounds known to be used in pet care products; compounds known to be used in personal care products; compounds known to be used in home products; pharmaceutical preparations; topical preparations; cannabis-derived or cannabis-related products; compounds known to be used in oral care products; beverages; scents, perfumes, or odorants; compounds known to be used in consumer products; silicone compounds; abrasives; surfactants; warming agents; smoking articles; fats, oils, or emulsions; and/or probiotic bacteria or supplements.

  本发明涵盖已知用于改变苦味感知的化合物和组合物，以及所述组合物和化合物与额外的组合物、化合物和产品的组合。示例组合物包括以下一种或多种：冷却剂；无活性药物成分；活性药用成分；食品添加剂或食品；调味剂或调味增强剂；食品或饮料产品；苦味化合物；甜味剂；苦味剂；酸味调味剂；咸味调味剂；鲜味调味剂；植物或动物产品；已知用于宠物护理产品中的化合物；已知用于个人护理产品中的化合物；已知用于家用产品中的化合物；制药制剂；局部制剂；大麻衍生或与大麻相关的产品；已知用于口腔护理产品中的化合物；饮料；香味、香水或除臭剂；已知用于消费品中的化合物；硅化合物；磨料；表面活性剂；发热剂；吸烟物品；脂肪、油脂或乳化剂；和/或益生菌或补充剂。
• COMPOUNDS USEFUL AS MODULATORS OF TRPM8
  申请人：Senomyx, Inc.

  公开号：US20170096418A1

  公开（公告）日：2017-04-06

  The present disclosure relates to compounds which are useful as cooling sensation compounds.

  本公开涉及作为冷感化合物有用的化合物。
• Dibenzofuran compounds and pharmaceutical/cosmetic compositions
  申请人：Centre International de Recherches Dermatologiques Galderma

  公开号：US05702710A1

  公开（公告）日：1997-12-30

  Novel pharmaceutically/cosmetically-active dibenzofuran compounds have the structural formula (I): ##STR1## wherein A is a radical having one of the formulae (IIa), (IIb) or (IIc): ##STR2## and are useful for the treatment of a wide variety of disease states, whether human or veterinary, for example dermatological, rheumatic, respiratory, cardiovascular and ophthalmological disorders, as well as for the treatment of mammalian skin and hair conditions/disorders.

  具有药用/化妆活性的新型二苯并呋喃化合物具有结构式（I）：##STR1## 其中A是具有式（IIa），（IIb）或（IIc）之一的基团：##STR2## 并且对于治疗各种疾病状态（无论是人类还是兽医），例如皮肤病，风湿病，呼吸系统疾病，心血管疾病和眼科疾病以及哺乳动物皮肤和毛发状况/疾病的治疗非常有用。
• NOVEL COCRYSTALLIZATION
  申请人：CHILDS Scott L.

  公开号：US20090281195A1

  公开（公告）日：2009-11-12

  The present disclosure relates to novel cocrystals and novel methods for cocrystallization. In particular, the disclosure includes cocrystals comprising a salt of an active agent, such as a chloride salt of an active pharmaceutical ingredient. The present disclosure also relates to methods of preparing cocrystals and methods for screening for solid state phases.

  本公开涉及新型共晶体和新型共晶化方法。具体而言，公开包括由活性剂的盐组成的共晶体，例如活性药物成分的氯化物盐。本公开还涉及制备共晶体的方法和筛选固态相的方法。
• ENERGETIC COCRYSTALS FOR TREATMENT OF A SUBTERRANEAN FORMATION
  申请人：HALLIBURTON ENERGY SERVICES, INC.

  公开号：US20160177698A1

  公开（公告）日：2016-06-23

  The present invention relates to energetic cocrystals, and to methods for using the same for treatment of a subterranean formation. In various embodiments, the present invention provides a method of treating a subterranean formation, the method including obtaining or providing a composition including energetic cocrystals. Each energetic cocrystal independently includes an energetic compound and a secondary material. The method also includes placing the composition in a subterranean formation.

  本发明涉及具有能量共晶体的相关技术，以及使用这些技术治疗地下地层的方法。在各种实施例中，本发明提供了一种治疗地下地层的方法，该方法包括获得或提供包括能量共晶体的组合物。每个能量共晶体独立地包括一个能量化合物和一个辅助材料。该方法还包括将该组合物放置在地下地层中。